BioCorRx Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b34633d1-8955-49dc-ba52-b2dbfc3edd12/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-4.8M | 2025-01-01 – 2025-12-31 | evidence 0001477932-26-001807 |
| FY 2024 | $-5.1M | 2024-01-01 – 2024-12-31 | evidence 0001477932-25-002219 |
| FY 2023 | $-3.8M | 2023-01-01 – 2023-12-31 | evidence 0001477932-24-001705 |
| FY 2022 | $-4.7M | 2022-01-01 – 2022-12-31 | evidence 0001477932-23-002039 |
| FY 2021 | $-5.5M | 2021-01-01 – 2021-12-31 | evidence 0001477932-22-001817 |
| FY 2020 | $-7.5M | 2020-01-01 – 2020-12-31 | evidence 0001477932-21-001909 |
| FY 2019 | $-5.6M | 2019-01-01 – 2019-12-31 | evidence 0001477932-20-001621 |
| FY 2018 | $-4.6M | 2018-01-01 – 2018-12-31 | evidence 0001477932-19-001764 |
| FY 2017 | $-2.9M | 2017-01-01 – 2017-12-31 | evidence 0001477932-18-001699 |
| FY 2016 | $-2.2M | 2016-01-01 – 2016-12-31 | evidence 0001477932-17-001708 |
| FY 2015 | $-5.1M | 2015-01-01 – 2015-12-31 | evidence 0001477932-16-009752 |
| FY 2014 | $-3.1M | 2014-01-01 – 2014-12-31 | evidence 0001477932-16-009752 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).